Caas Capital Management »

ResMed shares owned by Caas Capital Management

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Caas Capital Management from 13F filings

Historical chart of Caas Capital Management investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Caas Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Caas Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.9M 25k 198.03
2023-09-30 $739k 5.0k 147.87

More positions owned by Caas Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Citigroup Com New Call Option (C)
Wells Fargo & Company Call Option (WFC)
Netflix Call Option (NFLX)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Meta Platforms Cl A (META)
Goldman Sachs Call Option (GS)
Bank of America Corporation Call Option (BAC)
Chevron Corporation Call Option (CVX)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Alphabet Cap Stk Cl A (GOOGL)
Caterpillar Call Option (CAT)

View all positions for Caas Capital Management

Top funds holding ResMed

Vanguard Group
BlackRock
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
FMR
Northern Trust
Jpmorgan Chase & Co
Legal & General Group
Goldman Sachs Group
Charles Schwab Investment Management
Fil
Lgt Capital Partners
Ubs Global Asset Management Americas
Citadel Advisors

View all funds holding ResMed